Ironically, a side effect of excessive anticholinesterase treatment is excessive weakness or cholinergic crisis due to excessive stimulation of nicotinic receptors in the muscle end-plate region, resulting in a transient phase of uncontrolled muscle fasciculations due to sustained depolarization, followed by the development of receptor desensitization and a flaccid paralysis
Not the right fit for People expecting weight loss results comparable to pharmaceutical GLP-1 drugs
While further research is required to translate these preclinical findings into clinical practice, the identification of the GLP-1R/PPARG/ACSL1 pathway provides a clear roadmap for future investigations into the intersection of metabolic drugs and cancer immunotherapy in the future
Unlike many oral medications that remain stable at room temperature for extended periods, GLP-1 receptor agonists are sensitive to temperature fluctuations, light exposure, and time
In contrast, the GLP-1 elevations associated with allulose consumption appear modest and transient, with unclear clinical significance for glucose management or weight control
